Pomerantz LLP Announces Class Action Settlement for Gritstone Bio Investors
Pomerantz LLP has recently revealed important updates regarding a proposed class action settlement that relates to the purchasers of Gritstone bio, Inc. securities. This announcement comes following the United States District Court's approval in the Northern District of California, specifically from the San Francisco Division, which signifies a monumental step forward for those affected by the alleged securities violations.
The class action, identified as "IN RE GRITSTONE BIO, INC. SECURITIES LITIGATION," under Case No. 324-cv-03640-CRB, is an attempt to address the grievances of investors who purchased publicly traded shares of Gritstone between March 9, 2023, and April 2, 2024. These investors, known as the 'Settlement Class', are encouraged to take note of the settlement proceedings, as their financial interests may be significantly affected.
A critical hearing is set for December 4, 2026, at 10:00 a.m. in the San Francisco courthouse. This hearing will assess several fundamental aspects of the proposed settlement:
1. Settlement Approval: The Court will consider whether the proposed settlement amount, totaling $6 million, is fair, reasonable, and adequate for the affected parties.
2. Distribution Plan: Evaluating if the suggested plan for distributing the settlement proceeds meets fairness and reasonableness standards will also be on the agenda.
3. Counsel Fees: The application for attorney fees and litigation expenses will be reviewed. Specifically, Plaintiffs’ Counsel seeks an award of up to one-third of the settlement amount, equating to $2 million, alongside additional expenses that may amount to $500,000.
Participants are reminded that if they wish to be involved in the recovery from the settlement, submissions must be completed by November 13, 2026. This includes filling out the Proof of Claim and Release Form, which can be obtained from the Claims Administrator—Strategic Claims Services—or through their online portal. Failing to submit this form could lead to claims being rejected.
Any member of the Settlement Class looking to opt-out from participating in the settlement is required to submit an exclusion request following the guidelines laid out in the official notice before the same deadline. Consequently, anyone who does not take the step to opt-out will remain bound by the court’s decision regarding the settlement.
Additionally, objections to any part of the settlement or requests for attorney fees must be directed to the court by the set deadline, ensuring all concerns are adequately addressed during the review process.
Pomerantz LLP remains available for inquiries, as various stakeholders may have questions or require more information. Specifically, interested parties can contact Lead Counsel Samantha Daniels at their New York office, ensuring that all communications focus on the settlement rather than involving the court directly, as per court directives. This class action settlement represents a significant moment for Gritstone shareholders, uniting them in a collective effort to seek justice and resolution in relation to their investment losses.
In summary, this proposed settlement is a pivotal move for Gritstone bio investors, promising to address their financial losses due to alleged irregularities. Stakeholders are urged to remain informed and active as dates approach, marking a crucial chapter in this litigation journey.
The class action, identified as "IN RE GRITSTONE BIO, INC. SECURITIES LITIGATION," under Case No. 324-cv-03640-CRB, is an attempt to address the grievances of investors who purchased publicly traded shares of Gritstone between March 9, 2023, and April 2, 2024. These investors, known as the 'Settlement Class', are encouraged to take note of the settlement proceedings, as their financial interests may be significantly affected.
A critical hearing is set for December 4, 2026, at 10:00 a.m. in the San Francisco courthouse. This hearing will assess several fundamental aspects of the proposed settlement:
1. Settlement Approval: The Court will consider whether the proposed settlement amount, totaling $6 million, is fair, reasonable, and adequate for the affected parties.
2. Distribution Plan: Evaluating if the suggested plan for distributing the settlement proceeds meets fairness and reasonableness standards will also be on the agenda.
3. Counsel Fees: The application for attorney fees and litigation expenses will be reviewed. Specifically, Plaintiffs’ Counsel seeks an award of up to one-third of the settlement amount, equating to $2 million, alongside additional expenses that may amount to $500,000.
Participants are reminded that if they wish to be involved in the recovery from the settlement, submissions must be completed by November 13, 2026. This includes filling out the Proof of Claim and Release Form, which can be obtained from the Claims Administrator—Strategic Claims Services—or through their online portal. Failing to submit this form could lead to claims being rejected.
Any member of the Settlement Class looking to opt-out from participating in the settlement is required to submit an exclusion request following the guidelines laid out in the official notice before the same deadline. Consequently, anyone who does not take the step to opt-out will remain bound by the court’s decision regarding the settlement.
Additionally, objections to any part of the settlement or requests for attorney fees must be directed to the court by the set deadline, ensuring all concerns are adequately addressed during the review process.
Pomerantz LLP remains available for inquiries, as various stakeholders may have questions or require more information. Specifically, interested parties can contact Lead Counsel Samantha Daniels at their New York office, ensuring that all communications focus on the settlement rather than involving the court directly, as per court directives. This class action settlement represents a significant moment for Gritstone shareholders, uniting them in a collective effort to seek justice and resolution in relation to their investment losses.
In summary, this proposed settlement is a pivotal move for Gritstone bio investors, promising to address their financial losses due to alleged irregularities. Stakeholders are urged to remain informed and active as dates approach, marking a crucial chapter in this litigation journey.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.